| Identification | Back Directory | [Name]
2-Pyrazineacetamide, α-[(2-chloroacetyl)[4-(5-isothiazolyl)phenyl]amino]-N-(4,4-difluorocyclohexyl)-, (αR)- | [CAS]
2735704-19-3 | [Synonyms]
INSCoV-601I(1)
2-Pyrazineacetamide, α-[(2-chloroacetyl)[4-(5-isothiazolyl)phenyl]amino]-N-(4,4-difluorocyclohexyl)-, (αR)- | [Molecular Formula]
C23H22ClF2N5O2S | [MOL File]
2735704-19-3.mol | [Molecular Weight]
505.97 |
| Hazard Information | Back Directory | [Uses]
INSCoV-601I(1) is a potent inhibitor of Mpro (3CLpro). Proteases (PL pro and 3CL pro) are involved with transcription and replication of the virus. INSCoV-601I(1) has the potential for the research of SARS-CoV-2 infection (extracted from patent WO2021219089A1)[1]. | [References]
[1] Aleksandrs Zavoronkovs, et al. Sars-cov-2 inhibitors having covalent modifications for treating coronavirus infections. Patent WO2021219089A1. |
|
|